LXRX
LXRX
NASDAQ · Pharmaceuticals

Lexicon Pharmaceuticals Inc

$1.63
+0.02 (+1.24%)
As of May 9, 1:48 AM ET ·
Analyst Consensus
Buy
11
Analysts
Moderate
Coverage
Buy 8 73%
Hold 3 27%
Sell 0 0%
Price Target
Analyst Price Target +1,002.5% upside
Low Target $15.16
Average Target $17.97
High Target $22.64
Current Price $1.63
Current
$1.63
Target
$17.97
$15.16 $17.97 avg $22.64
Scenario Analysis
Bear Case
$15.16
830.1%
Low target
Base Case
$17.97
+1,002.5%
Avg target
Bull Case
$22.64
+1,289.0%
High target
Risk/Reward
1.6x
Balanced
Price in Context
52-Week High
$1.95
-16.4% from high
52-Week Low
$0.51
+217.3% from low
Target vs 52W High
$17.97
+821.5% vs high
Next Earnings Report
May 11, 2026
Today
EPS Est: $-0.04
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
RDY
Dr. Reddy's Laboratories
Hold 45 51% +0.0%
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +40.3%
JNJ
Johnson & Johnson
Buy 32 63% $299.55 +35.3%
MRK
Merck & Co. Inc.
Buy 35 71% $159.27 +43.0%
PFE
Pfizer Inc.
Hold 36 44% $33.90 +32.0%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +210.7%
ZTS
Zoetis Inc
Buy 25 60% $209.87 +153.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -28.6%